Company:
AMOMED Pharma GmbH
Member of the AOP Health Group
Leopold-Ungar-Platz 2
1190 Vienna
Media Owner and Publisher:
AOP Orphan Pharmaceuticals GmbH
Member of the AOP Health Group
Leopold-Ungar-Platz 2
1190 Vienna, Austria
Tel.: + 43 1 503 72 44
Fax.: +43 1 503 72 44 5
E-Mail: office[at]aoporphan.com
www.aop-health.com
Reporting of Adverse Drug Reactions: drugsafety[at]aoporphan.com
Company Purpose:
Manufacturing and wholesale of medicines and poisons. Manufacturing, processing, and wholesale of medical devices, insofar as these activities are not subject to any other regulation.
VAT Number: ATU57344706
Company registration number: FN 237770m
Company Register and Commercial court: Vienna, Austria
Headquarters: Vienna, Austria
Applicable Rules and Regulations:
Austrian Drug Law (AMG)
https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441
Austrian Medical Product Law (MPG)
https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011003
Austrian Trade, Commerce and Industry Regulation Act (Gewerbeordnung GewO 1994)
https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10007517
Regulatory Authority/Commercial Authority:
- Municipal authority for the 18th/19th District in Vienna, Austria conducting general business supervision
- Austrian Federal Ministry of Health conducting supervisory control
- AGES, Austrian Agency for Health and Food Safety
- Member of Economic Chamber Vienna, Austria
Online Dispute Resolution: Consumers have the possibility to submit complaints to the EU online dispute resolution platform: ec.europa.eu/odr. You can also send any complaints to the above e-mail address.
DISCLAIMER:
Health Information. This website may contain information referring to medical and health topics. This relevant information however does not offer an alternative to the advice of physicians, pharmacists or other representatives of the medical sector and are not to be used for self-diagnosis or for the diagnosis of others. Scientific data as well as information concerning the development of products or therapies are subject to premier publishing and thus, are always open to any type of change.